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Abstract	  
	  Through	  its	  toxic	  metabolites,	  acetaminophen	  can	  cause	  oxidative	  injury	  in	  the	  liver.	  This	  damage	  has	  not	  yet	  been	  investigated	  in	  the	  respiratory	  tract.	  If	  acetaminophen	  also	  causes	  oxidative	  stress	  and	  injury	  here,	  this	  widely	  used	  antipyretic	  could	  potentiate	  the	  adverse	  effects	  of	  oxidant	  air	  pollutants.	  Thus,	  the	  primary	  goal	  of	  this	  project	  is	  to	  determine	  if	  low	  non-­‐hepatotoxic	  doses	  of	  APAP	  is	  correlated	  with	  an	  increase	  of	  oxidative	  stress	  in	  the	  airways,	  possibly	  linking	  APAP	  to	  the	  onset	  of	  asthma.	  Using	  data	  that	  reflected	  murine	  breathing	  patterns,	  the	  addition	  of	  acetaminophen	  greatly increased the reflex irritant response to ETS through the 
potentiation of the oxidant sensory irritant, most likely caused by acetaminophen’s 
metabolite, NAPQI.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Doughty	   5	  
Introduction 
As defined by the National Heart, Lung, and Blood Institute, “Asthma is a chronic 
inflammatory disorder of the airways in which many cells and cellular elements play a 
role: in particular, mast cells, eosinophils, T lymphocytes, macrophages, neutrophils, and 
epithelial cells. In susceptible individuals, this inflammation causes recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the 
early morning. These episodes are usually associated with widespread but variable 
airflow obstruction that is often reversible either spontaneously or with treatment. The 
inflammation also causes an increase in the existing bronchial hyperresponsiveness to a 
variety of stimuli. Reversibility of airflow limitation may be incomplete in some patients 
with asthma.” (National Asthma Education and Prevention Program 2007). In other 
words, asthma is a chronic, lifetime condition that plagues people of all ages. Asthma 
severity and response to treatment can vary from person to person and both depend on the 
conjunction of the previously mentioned factors.  
One major feature of asthma is the inflammation of the airways. This 
inflammation is brought about by the exposure to allergens and irritants, such as tobacco 
smoke, which trigger an IgE-mediated event, resulting in the release of histamine, 
leukotrienes, and prostaglandins from mast cells. This inflammation is accompanied by 
bronchoconstriction and narrowing of the patient’s airways. These events are mainly in 
relation to bronchial smooth muscle contraction. Although exposure to irritants is a 
common factor associated with this constriction, other events can precipitate the same 
effects, including stress, exercise, and exposure to cold air. In particular, sensitized mast 
cells may be activated by osmotic stimuli in addition to irritants and allergens. Osmotic 
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stimuli are believed to mediate bronchoconstriction in exercise-induced asthma (National 
Asthma Education and Prevention Program 2007). In fact, osmotic/exercise-induced mast 
cell activation leads to the same mediator release and bronchoconstriction of similar 
magnitude as allergens. These mechanisms of non-allergic events are less well defined 
but they still contribute to the overall spectrum of asthmatic diseases (Myers and Tomasio 
2011). 
 The prevalence of asthma worldwide is growing at an alarming rate. As of recent, 
approximately 235 million people across the globe currently battle with asthma, and 
approximately 250,000 people die from it each year. The incidence of American children 
being diagnosed with the disease each year is about 9.5%, contrasted with the same data 
point some 30 years ago of approximately 3.6% (National Asthma Education and 
Prevention Program 2007). How has asthma integrated so quickly into today’s human 
population? Everything from host factors to environmental precipitants has been 
proposed to play some part in this modern day epidemic.  
 Utilizing serum IgE concentrations as a surrogate endpoint, recent studies have 
shown that those with first-degree relatives affected by asthma have a 20-25% risk of 
contracting the disease, contrasted with approximately 4-8% in a normal population. 
More specifically, those children with a mother who presents with atopic, or allergic, 
asthma, as discussed previously, have a higher risk of contracting asthma than those with 
an atopic father. With these data in mind, a genetic association seems to be apparent. 
However, recent studies centered on genetic associations have yet to confirm any such 
lineage. Recent data have only been able to suggest a possibility of association or confirm 
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a genetic link to only one phenotypic characteristic of the overarching disease (National 
Asthma Education and Prevention Program 2007).  
Worldwide, about 250,000 people die from asthma each year. Approximately 
80% of this mortality stems from low or middle income countries. The other 20% of 
deaths may occur in higher standing countries, but the majority of the deaths are found to 
occur to people with lower socioeconomic standing. This association between economic 
standing and the onset of asthma suggests some correlation with socioeconomic status 
and disease. Further, this association could possibly be due to the increased amounts of 
irritants that lower income families are exposed to, triggering more atopic reactions to 
take place, or due to a lack in accessing healthcare. Another common difference present 
throughout families of varying economic standings is diet. Thus, one’s diet may influence 
the development of asthma, further justifying the possibility of environmental causation.  
At the forefront of the environmental component of asthma lies the hygiene 
hypothesis. This hypothesis revolves around an overabundance of thymus helper type 2 
lymphocytes (TH2) cells over TH1 thymus helper type 1 lymphocyte (TH1) cells. This 
higher concentration of TH2 cells can be caused by a variety of correlating factors, 
including the widespread use of antibiotics, a sensitization to house-dust mites and 
cockroaches, an urban environment, and a Western lifestyle. On the other hand, those 
having older siblings, an early exposure to day care, tuberculosis, measles, or hepatitis A 
infection, or a rural home setting are more likely to develop an abundance of TH1 cells. 
Thus, those with a larger amount of TH1 cells are less likely to develop asthma.  This 
hypothesis is highly reliant on the assumption that the immune system of a newborn is 
skewed towards the TH2 cell over the TH1 cell. Thus, lack of those stimuli that promotes 
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the development of TH1 cells seems to be the ultimate causative factor. Further, the 
production of TH2 cells promotes signal cascades that decrease the production of TH1 
cells and vice versa, providing further conceptual support for this hypothesis (Myers and 
Tomasio 2011). However, is there a genetic indication that promotes the development of 
TH2 cells over TH1 cells that coincides with this hypothesis? This question proposes 
some sort of balance between the two contributing factors.  
With the hygiene hypothesis in mind, one of the most obvious environmental 
contributors to the development of asthma is the presence of allergens in the 
environment. Although the role of allergens has not been fully defined, the activation of 
an IgE mediated reaction generally leads to inflammation and a TH2 response. Long-term 
exposure to allergens can cause a dominant TH2 presence as well as continuous allergic 
inflammation, leading to the onset of asthma. Among the most common allergens shown 
to have an association with the development of asthma are dog and cat dander. However, 
at the same time, some current research has shown that early exposure to these allergens 
could help prevent the onset of asthma, leaving many questions unanswered. Also, 
exposure to the cockroach, mouse, or dust mite allergens may play a large role in the 
development of asthma in urban settings (Kazani and Israel 2012).  
Correlations also exist that tie air pollution, smoking, and a poor diet to the 
development of asthma. However, up to this point, the involvement of irritants and 
allergens have likely only painted half of the picture. More specifically, in the past few 
years, both an increase in the use of acetaminophen containing products in children and 
an increase in asthma prevalence have been observed. Thus, an association between 
acetaminophen and asthma has been suggested (Eccles	  2006).   
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Today, acetaminophen, also known as Tylenol and referred to herein as APAP (n-
acetyl-para-aminophenol), is the most commonly used antipyretic and analgesic in the 
United States. The medication is indicated as monotherapy for both fever and mild to 
moderate pain as well as adjunct therapy for moderate to severe pain. The drug has also 
been utilized as prophylactic treatment for many conditions, including headaches, as well 
as for osteoarthritis pain. APAP is available as both brand and generic over the counter. 
However, the drug is also found in a variety of prescription and over the counter 
combination products, including Percocet, Vicodin, and Fioricet. The use of APAP 
combined with other medications in recent history has greatly contributed to the 
increased intake in today’s population. Although these combination products have proven 
to be very beneficial in some cases, their use has also been shown to increase one’s risk 
of overdosing on APAP as many do not account for the additional APAP when taking the 
product (Eccles	  2006). 
An oral APAP overdose for an adult is defined as taking over 4 grams of the 
product per day for several weeks or taking over approximately 10 grams in less than 8 
hours. Fatalities occur with acute doses of over 15 grams. For infants, an acute overdose 
of 150mg/kg or higher has been associated with adverse effects. The recommended 
monotherapy dose is approximately 15 mg/kg/dose every 4-6 hours, not to exceed 4 
grams per day if taking the medication over the counter. The drug is also available as an 
IV formulation with a similar dosing schedule and toxicity range. It has also been noted 
that infants under the age of 2 should not receive APAP over the counter. However, the 
oral drug can be prescribed down to the age of 3 months (Eccles	  2006). 
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APAP exerts its analgesic and antipyretic effects centrally, with minimal if any 
anti-inflammatory activity. Although its mechanism of action is still under investigation, 
it has been proposed to involve inhibition of the cyclooxygenase (COX) enzymes. More 
specifically, it has been proposed that the drug inhibits a COX-3 variant more specifically 
than COX-1 or COX-2 (DRUGDEX®	  System). This inhibition has been shown to 
contribute to an elevation in the overall pain threshold and reduction in pyretic activity. 
Due to the inconclusive evidence for the actual mechanism of APAP, other pathways 
have been suggested, including one involving the activation of cannabinoid receptors and 
another inducing hypoalgesia via substance P. Along with the inhibition of the COX 
enzymes, the antipyretic effects may also be potentiated by inhibiting endogenous 
pyrogens in the hypothalamic thermoregulatory center (DRUGDEX®	  System).   
The metabolism of APAP takes place primarily in the liver when administered 
orally and involves both toxic and non-toxic metabolites. The main metabolic pathway 
has been shown to be glucuronidation, closely followed by sulfation and N-hydroxylation 
and rearrangement. The toxicity does not stem from the final products of these three 
pathways. Instead, the toxicity of APAP derives from a free radical intermediate, N-
acetyl-P-benzoquinone-imine (NAPQI), formed from the N-hydroxylation and 
rearrangement pathway.  NAPQI is highly reactive, causes cellular oxidative stress, and 
covalently binds to cellular macromolecules. Cytochrome P450 plays a major role in this 
pathway; polymorphisms found in this cytochrome’s three main isoenzymes, CYP 2D6, 
CYP 1A2, and CYP 2E1, can account for the varying toxicities found across the 
population. In most cases, the production of NAPQI is followed by its detoxification via 
glutathione conjugation; however, toxicity can occur when this pathway becomes 
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saturated. Saturation can be prompted when one overdoses on APAP or when one’s 
metabolism of the drug is increased, as seen in rapid metabolizers. The overproduction of 
NAPQI cannot be counterbalanced by the amount of glutathione available. Eventually, 
glutathione stores are depleted and the toxic metabolite is available to react with tissue 
macromolecules (Borne	  1995). 
The main target organ of APAP toxicity is the liver. Because the drug is 
metabolized through the liver and produces NAPQI in some instances, this toxic 
metabolite covalently binds to the liver protein, resulting in the loss of function and 
possible cytotoxicity. More specifically, James has hypothesized that the primary target 
of the toxic metabolite are the mitochondrial proteins of the cell, thus limiting energy 
production and leading to cell death. Of the many enzymes affected by NAPQI, N-10-
formyltetrahydrofolate dehydrogenase has been identified as a biological target for 
NAPQI adduction. More specifically, this enzyme is responsible for oxidizing 
formaldehyde to carbon dioxide. With the inactivation of this enzyme, liver injury is 
imminent. A second enzyme revealed by James is the 50-kDa mitochondrial protein 
responsible for the dehydrogenation of glutamate. Although only partially inactivated by 
the covalent binding of NAPQI, both of these enzymes are greatly slowed, which can 
exert a large amount of toxicity on the liver (James et al. 2003).  
Asthma has been shown to be associated with general APAP consumption (less 
than once a month use for an average of 4-5 days). In contrast to the effects on the liver, 
patients who have been involved in the proposed link between asthma and APAP have 
taken therapeutic doses of APAP, instead of an overdose. More specifically, a 
retrospective study dating back to 1994 has shown that as the sale of APAP in English 
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speaking countries has increased, so has the prevalence of asthma. Many have 
hypothesized that this increase in prevalence is directly correlated with the increased 
consumption of APAP. This possible link is supported by the glutathione depleting 
effects of APAP in the liver. If a similar depletion in the airways occurs alongside that 
that takes place in the liver, this decrease in the antioxidant, glutathione, leaves the 
individual more susceptible to oxidative stress brought about by other irritants, even at 
the proper dosing schedule. Increases in inflammatory mediators as well as oxidative 
stress have been suggested to correlation with the onset of asthma. Thus, this decrease in 
airway antioxidant potential could possibly be linked to the increase in atopic asthma 
symptoms (Newson et al. 2000). Studies of the effects of low doses of APAP on the 
respiratory tract are largely absent. A study that investigates glutathione loss following 
APAP in the airways is necessary to determine whether this is a possible mechanism for 
the increase in disease in the last 30 years. Thus, the primary goal of this project is to 
determine if low non-hepatotoxic doses of APAP is correlated with an increase of 
oxidative stress in the airways, possibly linking APAP to the onset of asthma.  
Overall, asthma has been shown to be a multifactorial disease that is a 
culmination of both genetic and environmental causative factors. Although much work 
has been done thus far to determine the ultimate causes and potential therapies to combat 
the disease state, much work is still to come. Of the many environmental factors that 
remain unclear, the use of acetaminophen and its correlation with asthma may show some 
promise in future studies. Also, as mentioned before, the exposure of youth to irritants 
has shown a correlation with the onset of asthma. Thus, the exposure to environmental 
tobacco smoke also shows a correlation with the onset of asthma; however, a definitive 
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mechanism has yet to surface. Hopefully, by exposing these and other existing 
correlations, the etiology of the complex and multifactorial disease that is asthma will 
begin to become clearer, opening up new avenues for therapeutic intervention.  
The current study is focused on determining if APAP induces oxidative stress in 
respiratory tissues and whether the respiratory irritation effects of exposure to acrolein, a 
primary chemical component of environmental tobacco smoke (ETS), is enhanced by the 
stress. Acrolein was selected as it allows for a more mechanistic understanding of the 
pro-irritant capacities of ETS, which has been shown to contribute to the increased 
prevalence of asthma. Acrolein is a known pro-oxidant that interacts with the transient 
receptor potential cation channel, subfamily A, member 1 (TRPA1) to produce the 
respiratory irritant-induced sensory irritation response.  
 
Materials and Methods 
Experimental Approaches.  The hypothesis that the metabolites of APAP act as pro-
oxidants in the airways and increases the body’s response to acrolein was tested in a 
mouse model. Towards this end, animals were euthanized 0-3 hrs after 100 mg/kg APAP 
administration (ip). The role of oxidative stress in inducing the irritant reflex response 
was examined by multiple approaches.  First, the effects of APAP on the responses to the 
pro-oxidant irritant acrolein, and the non-oxidant irritant cyclohexanone were examined 
to confirm any effects of APAP were oxidant specific rather than generalized in nature.  
Cyclohexanone activates chemosensory nerves by the transient receptor potential vanillin 
1 (TRPV) receptor (Saunders et al. 2013; Willis et al. 2011).  Second, the effect of APAP 
was examined in animals pretreated with 5-phenyl-1-pentyne (5-PP) to inhibit nasal CYP 
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metabolism (Roberts et al. 1998; Morris and Buckpitt 2009; Morris 2013) and 
bioactivation of APAP.  (Bioactivation of APAP is necessary for its pro-oxidant effects.)  
Third, the glutathione depleting agent, diethylmaleate (DEM), was administered to 
determine if modulation of nasal antioxidant status could replicate the effects of APAP.  
This agent is conjugated with glutathione via glutathione-S-transferases, resulting in 
depletion of tissue glutathione levels (Phimister et al. 2004; Boyland and Chasseaud 
1967).  
Animal procedures.  Female C57Bl/6J mice were used for all experiments. Mice 
were obtained from Jackson Laboratories (Woods Hole, MA, USA) and housed in 
American Association for Accreditation of Laboratory Animal Care-accredited facilities 
at the University of Connecticut under standard environmental conditions (12-h light-
dark cycle at 23°C). Mice were housed over hardwood shavings (Sani-Chip Dry, P. J. 
Murphy Forest Products, Montville, New Jersey). Food (Lab Diet; PMI Nutrition 
International, Brentwood, Missouri) and tap water were provided ad libitum. Animals 
were 7 weeks of age on arrival, were acclimated for at least 10 days prior to use and were 
used within 10 weeks of arrival. All animal procedures were approved by the University 
of Connecticut Institutional Animal Care and Use Committee. 
APAP, dissolved in warm 37o C saline (10 mg/ml), was administered via ip 
injection at a dose of 100 mg/kg.  When administered, the cytochrome P450 inhibitor 5-
PP was given ip at a dose of 100 mg/kg (10 mg/ml in olive oil) 1hr prior to APAP 
treatment (Morris 2013).  Diethylmaleate was administered at a dose of 250 mg/kg (0.5 
M solution in corn oil, ip, Phimster et al. 2005). Control animals received vehicle 
injections.  Mice were exposed to airborne irritants as described below; irritant exposure 
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concentrations were selected to produce demonstrable, but submaximal irritation.  For 
euthanasia and tissue collection, mice were anesthetized with urethane (1.3 g/kg) 
followed by exsanguination (Cichocki et al. 2014a). 
Breathing Pattern Analysis.  Mice were held in a double plethysmograph (Buxco, 
Inc, Sharon, Connecticut) connected to a directed airflow nose-only inhalation chamber 
(CH Technologies, Westwood, New Jersey) for irritant exposure to allow monitoring of 
breathing parameters during the exposure. Animals were placed in the plethysmograph 
for a 15-min acclimatization, 5-min baseline, and then a 10 minute exposure to irritant. 
Stimulation of nasal trigeminal nerves induces the reflex sensory irritation response that 
is characterized by a pause at the onset of each expiration (due to glottal closure), termed 
braking, and is quantitated by measuring the duration of the braking (Willis et al. 2011).  
Breathing patterns were monitored continuously during the baseline and exposure periods 
using Emka Technologies (Falls Church, Virginia) Iox 2 software.  
Respiratory Irritant Exposures.  Mice were exposed to ETS for 10 minutes or to 
the irritant vapors, acrolein or cyclohexanone, for the same duration.  Mice were 
continuously exposed to constant levels of irritant to allow for the most precise 
estimation of irritant- or APAP- induced changes in breathing. For exposure clean- or 
irritant-laden air was drawn into the headspace of the double plethysmograph at a flow 
rate of 1L/min.   
Acrolein (nominal concentration 2 ppm) atmospheres were generated by flash 
evaporation; cyclohexanone (nominal concentration, 1500 ppm) atmospheres were 
generated by passing filtered air through liquid cyclohexanone in a gas washing bottle;  
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airborne vapor concentrations were monitored by gas chromatography using a Varian 
3800 gas chromatograph as described previously (Willis et al. 2011).  
Statistical Analysis.  Numbers of animals per group were selected to detect a 25% 
difference between groups based on our previous experience with the methodologies.  
Data were analyzed by XLSTAT (Addinsoft, New York, New York).  Individual data 
values were excluded a priori if they deviated from the mean by more than 3 standard 
deviations. Data are reported as mean + SE unless otherwise indicated. Data were 
compared by an Unpaired T-Test or ANOVA followed, as appropriate, by Newman-
Keuls test.   When appropriate data were log transformed to correct for 
heteroscedasticity.  The sensory irritation response was assessed by monitoring duration 
of braking throughout the irritant exposure; for time course studies these data were 
analyzed by repeated-measures ANOVA followed by Newman-Keuls test.   A p-value 
less than 0.05 was required for statistical significance.   
 
Results  
As illustrated in 
Figure 1, mice were 
exposed to acrolein and 
APAP (n = 8) or 
acrolein alone (n = 16), 
following the 
aforementioned 
procedure. The mice Figure	  1:	  The	  above	  figure	  shows	  the	  effect	  that	  APAP	  has	  on	  enhancing	  acrolein	  induced	  sensory	  irritations,	  reflected	  in	  the	  mice’s	  duration	  of	  breaking.	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that were exposed to acrolein alone showed a moderat sensory irritation response as 
indicate by an increase in braking over the exposed interval (t = 0 – 10 min). To increase 
validity, data used to represent acrolein alone were pooled from three groups: acrolein 
with saline, acrolein with 5-PP, and acrolein with corn oil due to the results illustrated in 
figure 3, as statistical analyses revealved that the response to acrolein was not altered by 
any of these vehicle treatments. A reported experimental time interval of t = 10 min was 
utilized due to increased variation beyond this interval, as seen in the following figures as 
well. While APAP alone did not produce the irritation response, animals pretreated with 
APAP demonstrated a much greater irritation response to acrolein.  Utilizing a two-tailed 
student’s t-test, the difference between the average response to acrolein alone and the 
average response to acrolein with APAP pretreatment were found to be significant with a 
p value of <0.0007 (ave. of t= 0 to t = 10). Tables 1 and 2 further elaborate on the data set 
forth in figure 1, showing the additional analyses of average minute ventilation (MV), 
tidal volume (TV), and frequency (f) of the specified mice in the time interval noted. 
Both tables show that the minute ventilation decreased, tidal volume increased, and 
frequency decreased in response to the addition of acrolein when compared to baseline. 
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Additionally, when 
pretreated with APAP, 
the mice tended to 
breathe at a lower 
frequency and, thus, 
higher tidal volume 
when being exposed to 
acrolein to take in the 
same (or relatively 
same) amount of air.   
 Figure 2 shows 
the results of mice 
being exposed to both cyclohexanone alone (n = 7) as well as cyclohexanone combined 
with APAP (n = 4). As seen in the figure, very little differences were observed between 
the two study groups. This lack of significant difference was confirmed by a comparison 
of the two groups, utilizing a two-tailed student’s t-test (p = 0.953). Tables 3 and 4 also 
show very little difference in trends between pre-exposure and exposure time periods.  
Figure	  2:	  The	  above	  figure	  show	  the	  effect	  that	  APAP	  has	  on	  the	  sensory	  irritation	  of	  cyclohexanone,	  reflected	  in	  the	  mice’s	  duration	  of	  breaking.	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 Figure 3 illustrates 
the average durations of 
breaking of the following 
vehicles: acrolein plus 5-PP 
(n = 2), acrolein plus saline 
(n = 7), acrolein plus corn oil 
(n = 3), acrolein plus olive 
oil (n = 2) and acrolein alone 
(n = 2). More specifically, 
these numbers represent the 
average duration of breaking 
of mice exposed to the 
specified vehicles during the 
Figure	  3:	  The	  above	  figure	  represents	  the	  average	  irritation	  response	  of	  the	  specified	  population	  of	  mice	  from	  t	  =	  0	  min	  to	  t	  =	  10	  min.	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interval of 2-10 minutes. As mentioned previously, this figure shows that little 
differences exist between the five selected vehicles, with a p value greater than 0.05 for 
each calculated using the 1-Way ANOVA test, followed by a Newman-Keuls test for 
multiple comparisons, from minutes 2-10. Tables 1, 5, 6, 7, and 8 further illustrate this 
non-significant difference. 
 Figure 4 shows 
the effect of 5-PP 
administration 1 hour 
prior to APAP on the 
acrolein response. (n = 
5). As seen before, 
acrolein produced a 
moderate irritation 
response; this response 
was greatly enhanced 
in animals pretreated 
Figure	  4:	  The	  above	  figure	  shows	  the	  effect	  that	  5-­‐PP	  has	  on	  the	  toxicity	  of	  APAP	  and	  acrolein,	  reflected	  in	  the	  mice’s	  duration	  of	  breaking.	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with APAP.  This effect of APAP was absent in mice treated with the CYP inhibitor 5-
PP. Thus, the response in 5-PP closely resembled that of acrolein alone (n = 16), 
supported by a p value of 
greater than 0.05 for the 
5-PP and APAP as well 
as the acrolein alone 
groups, obtained using a 
1-Way ANOVA Test and 
a Newman-Keuls Test. 
Table 9 also shows a 
very similar trend to that 
seen in table 1, which 
supports the non-
significant difference 
between the two vehicles.  
 Figure 5 shows the effects of DEM, a non-toxic glutathione depleter, on the 
acrolein response. Similar to APAP, DEM greatly increased the response to acroline.  
Figure	  5:	  The	  above	  figure	  shows	  the	  effect	  that	  DEM	  has	  on	  enhancing	  acrolein	  induced	  sensory	  irritations,	  reflected	  in	  the	  mice’s	  duration	  of	  breaking.	  	  	  
Doughty	   22	  
With a p value of 0.0014, obtained using a two-tailed student’s t-test, the differences 
between the breathing patterns produced by mice when exposed to acrolein alone (n = 16) 
versus acrolein plus DEM (n = 6) prove to be significant. Further, the values and trend 
represented in table 10 resembles that shown in table 2.  
 Finally, figure 6 
shows the average 
duration of breaking of 
the mice exposed to the 
specified vehicle over 
the course of 0-10 min 
of exposure. As 
supported by the shown 
p values, obtained 
using a 1-Way 
ANOVA Test, little 
differences existed 
between acrolein alone (n = 16) and acrolein combined with 5-PP and APAP (n = 5), as 
mentioned in figure 4 as well. The same principle held true when comparing acrolein 
combined with APAP (n = 8) and acrolein combined with DEM (n = 6). However, when 
contrasting the two aforementioned groups, a significant difference existed, as shown by 
the p values under 0.05, suggested greater durations of breaking in those mice exposed to 
acrolein and APAP as well as those exposed to acrolein and DEM.  
 
Figure	  6:	  The	  above	  figure	  shows	  the	  average	  irritation	  response,	  represented	  by	  average	  duration	  of	  breaking,	  of	  the	  specified	  populations	  of	  mice	  from	  t	  =	  0	  min	  to	  t	  =	  10	  min.	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Discussion 
The present study demonstrates that APAP, at near therapeutic doses, modulates 
respiratory responses to acrolein, the primary oxidant sensory irritant in tobacco smoke. 
More specifically, the common analgesic APAP enhances one’s response to oxidant air 
pollutants, a concept that has not been investigated in the past. As mentioned previously, 
this study utilized APAP doses of 100 mg/kg, contrasted to a recommended dose in 
humans of 15 mg/kg. It has been shown that therapeutic levels of APAP fall between 5-
20 ug/ml, and hepatotoxicity occurs at blood levels of around 150 ug/mL (Rumack and 
Matthew 1975). Although the dosing in this study falls above the recommended dosing 
for a therapeutic response, the peak blood levels of APAP were approximately 35 ug/mL, 
following a 100 mg/kg dose (Morris Lab, Unpublished Data), which falls well below the 
threshold for hepatotoxicity. Previous studies by other groups have also shown that 
APAP blood levels in a mouse model are approximately 40 ug/mL at 15 minutes post-
injection at the 100 mg/kg dose. These levels then fall to therapeutic levels, 
approximately 35 ug/mL, within 1 hour post-injection, validating the previous point (Gu 
et al. 2005).  
Previous studies have shown that APAP, at overtly toxic doses, depletes nasal 
glutathione stores (Gu et al. 2005). This depletion likely leads to an oxidative stress 
response in the airways (Cichocki et al. 2014a, b). These events have not been 
investigated at therapeutic doses of APAP in the airways. However, the current study 
suggests that therapeutic doses of approximately 100 mg/kg in a mouse model result in 
local activation of APAP, leading to enhanced oxidant sensitivity caused by its 
metabolite, NAPQI. The results in this study do not rule out other possibilities, such as 
Doughty	   24	  
hepatic events (escape of activated APAP or depletion of blood glutathione), as 
contributing factors to the oxidative stress response that affects the respiratory tract 
(Phimister et al. 2005; Gu et al. 2005). Nevertheless, our results demonstrate that APAP 
causes a significant modulation of airway sensitivity to oxidant chemicals.  
The first experiments were aimed at exploring the oxidant sensory irritant 
properties of both acrolein and APAP. As figure 1 illustrates,  APAP clearly potentiated 
the sensory irritation response to acrolien. Alone, acrolein only produces a moderate 
braking response  in the mouse’s breathing, suggesting moderate irritation. As shown 
above, APAP alone does not increase the mouse’s irritation response (Morris Labs, 
Unpublished Data). However, when pretreated with APAP one hour prior to acrolein 
exposure, the braking response is potentiated. As mentioned previously, this additional 
braking response is most likely a result of glutathione depletion in the airways, brought 
about via NAPQI (Gu et al. 2004). Normally, glutathione is utilized to detoxify acrolein, 
leaving the airways unharmed. Thus, by reducing the amount available, increased oxidant 
sensory irritation is imminent. The results of this figure are strengthened by those found 
when the mice were pretreated with DEM, a known glutathione depleting agent, one hour 
prior to acrolein exposure. The similar trends in both the irritation response as well as the 
values shown in table 10 (comparing them to table 2) suggest that APAP at therapeutic 
doses had a glutathione depleting effect, leading to enhanced irritation.   
The potentiation observed when administering APAP prior to acrolein exposure 
suggests that APAP can alter complex integrated airway responses via pro-oxidant 
mechanisms. More specifically, the addition of APAP to acrolein caused prolonged 
breaking in the mouse’s breathing pattern, which stems from the stimulation of 
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chemosensory nerves via the oxidant sensitive TRPA1 receptor (Andre et al. 2008). In 
addition to adding APAP to a TRPA1 agonist, the effects of APAP on a known TRPV1 
agonist, cyclohexanone, were also observed to confirm or refute the specific pro-oxidant 
nature of APAP (figure 2). Because cyclohexanone is not an oxidant, the results from 
these experiments showed that little difference exists between cyclohexanone alone and 
cyclohexanone combined with APAP, thus confirming the specific pro-oxidant toxicity 
of APAP.  
Because it is known that APAP is activated and metabolized via CYP enzymes in 
the respiratory tract, independent of the metabolism that occurs within the liver, DEM 
treatment was utilized to imitate the gluthathione depletion that APAP is responsible for 
(Gu et al. 2005). Given at a dose that produced similar amounts of glutathione depletion 
to APAP, DEM showed similar trends when combined with acrolein to those shown by 
APAP and acrolein, suggesting that this depletion of glutathione may be the major 
pathway in APAP’s enhancement of acrolein sensory irritation.  
After confirming that the effects of APAP were pro-oxidant in nature, this study 
utilized a known cytochrome P450 inhibitor to confirm or refute that APAP’s effects on 
respiratory responses to oxidants stemmed from a metabolite, likely NAPQI, produced 
via CYP enzymes, rather than the parent compound. As seen in figure 4 and figure 1, 
when combined with acrolein, APAP has a synergistic effect. However, when 5-PP is 
added to the previously mentioned vehicles, the trend resembles that set by acrolein 
alone. This decrease in braking brought on by the addition of 5-PP suggests that APAP 
metabolites are not being formed due to CYP inhibition, leading to less toxicity in the 
airways at this dose. This also confirms the notion that an APAP metabolite, likely 
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NAPQI, is the causative species in this potentiation scenario. The above conclusions are 
summarized in figure 6, which shows the similarities between acrolein alone and the 
aforementioned 5-PP combination as well as those between the DEM/acrolein 
combination and the APAP/acrolein combination.  
The current study focuses primarily on the acute respiratory response to ETS and 
other oxidant air pollutants, represented by acrolein. As mentioned previously, with the 
“APAP hypothesis” regarding the increased in asthma prevalence in mind, air pollutants 
and airway oxidative stress are major factors when looking at the onset of asthma in 
today’s population due mainly to the increase of pro-inflammatory factors upon exposure 
(Reidl and Nel 2008; Holguin 2013). Because this study demonstrates that APAP 
increases murine respiratory responses to pro-oxidant irritation, it suggests that APAP 
may have a role in increasing one’s likelihood of developing asthma. Because this study 
was conducted in the acute setting, further investigational studies may be implicated for 
more long term trends between therapeutic levels of APAP and the onset of asthma. 
Regardless, this study confirms that even at therapeutic doses, APAP can elicit a toxic 
response.  
 
Conclusion 
This study shows that when APAP is given at therapeutic doses, pro-oxidant 
toxicities are present in a mouse model. These toxicities potentiate the acute airway 
response to ETS and could lead to an inflammatory response. That said, the therapeutic 
use of APAP may be detrimental to those regularly exposed to environmental toxins and 
lead to the onset of asthma, as supported by the APAP hypothesis.  
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